In a Chinese cohort, PCE and China-PAR overestimated 10-year ASCVD risk, PREVENT underestimated it, but recalibration improved risk estimation accuracy.
Does recalibration of PCE, China-PAR, and PREVENT models improve the estimation of 10-year ASCVD risk in a Chinese cohort?
Recalibration of established ASCVD risk models (PCE, China-PAR, PREVENT) is necessary to accurately estimate 10-year risk and enhance primary cardiovascular prevention in Chinese populations.
Absolute Event Rate: 0% vs 0%
In this Chinese cohort, the original PCE and China-PAR overestimated 10-year ASCVD risk, whereas PREVENT underestimated it. Recalibration mitigated such misestimation in the local population, potentially enhancing risk stratification in primary cardiovascular prevention in China.
Li et al. (Sun,) reported a other. In a Chinese cohort, PCE and China-PAR overestimated 10-year ASCVD risk, PREVENT underestimated it, but recalibration improved risk estimation accuracy.